FdaApplication
ANDA 219448
Identifiers
- fda_app_no: ANDA219448
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2026-07-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SUGAMMADEX SODIUM | SUGAMMADEX SODIUM | EQ 200MG BASE/2ML (EQ 100MG BASE/ML) | SOLUTION;INTRAVENOUS |
1 product